DZ1961A1 - Nouveaux composés. - Google Patents
Nouveaux composés.Info
- Publication number
- DZ1961A1 DZ1961A1 DZ960002A DZ960002A DZ1961A1 DZ 1961 A1 DZ1961 A1 DZ 1961A1 DZ 960002 A DZ960002 A DZ 960002A DZ 960002 A DZ960002 A DZ 960002A DZ 1961 A1 DZ1961 A1 DZ 1961A1
- Authority
- DZ
- Algeria
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36996495A | 1995-01-09 | 1995-01-09 | |
US08/472,366 US5593992A (en) | 1993-07-16 | 1995-06-07 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ1961A1 true DZ1961A1 (fr) | 2002-02-17 |
Family
ID=27004764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ960002A DZ1961A1 (fr) | 1995-01-09 | 1996-01-06 | Nouveaux composés. |
Country Status (34)
Country | Link |
---|---|
US (5) | US5593992A (fr) |
EP (2) | EP0809499B1 (fr) |
JP (2) | JP3330952B2 (fr) |
CN (1) | CN1138546C (fr) |
AP (1) | AP1270A (fr) |
AR (1) | AR002267A1 (fr) |
AT (1) | ATE254613T1 (fr) |
AU (1) | AU705207C (fr) |
BG (1) | BG63769B1 (fr) |
BR (1) | BR9606904A (fr) |
CA (1) | CA2209938A1 (fr) |
CZ (1) | CZ215897A3 (fr) |
DE (1) | DE69630777T2 (fr) |
DK (1) | DK0809499T3 (fr) |
DZ (1) | DZ1961A1 (fr) |
ES (1) | ES2210348T3 (fr) |
FI (1) | FI972901A (fr) |
HK (1) | HK1003623A1 (fr) |
HU (1) | HUP9702409A3 (fr) |
ID (3) | ID23599A (fr) |
IL (7) | IL134323A (fr) |
IN (3) | IN184957B (fr) |
MA (1) | MA23770A1 (fr) |
MX (1) | MX9705142A (fr) |
NO (3) | NO973167L (fr) |
NZ (1) | NZ301204A (fr) |
OA (1) | OA10738A (fr) |
PL (1) | PL322249A1 (fr) |
PT (1) | PT809499E (fr) |
RU (2) | RU2196139C2 (fr) |
SI (1) | SI0809499T1 (fr) |
SK (1) | SK90297A3 (fr) |
TW (1) | TW523511B (fr) |
WO (1) | WO1996021452A1 (fr) |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
US5871934A (en) * | 1993-09-17 | 1999-02-16 | Smithkline Beecham Corporation | Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
US6203803B1 (en) | 1994-12-14 | 2001-03-20 | Societe L'oreal S.A. | Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
KR19980701374A (ko) * | 1995-01-12 | 1998-05-15 | 스티븐 베네티아너 | 신규 화합물(Novel Compounds) |
EP0737471A3 (fr) * | 1995-04-10 | 2000-12-06 | L'oreal | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
US6369068B1 (en) | 1995-06-07 | 2002-04-09 | Smithkline Beecham Corporation | Amino substituted pyrimidine containing compounds |
IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
ZA9610687B (en) * | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
AP9700912A0 (en) * | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
AU715900B2 (en) * | 1996-01-11 | 2000-02-10 | Smithkline Beecham Corporation | Novel substituted imidazole compounds |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
WO1997032583A1 (fr) * | 1996-03-08 | 1997-09-12 | Smithkline Beecham Corporation | Utilisations de composes csaidtm en tant qu'inhibiteurs de l'angiogenese |
US6096739A (en) * | 1996-03-25 | 2000-08-01 | Smithkline Beecham Corporation | Treatment for CNS injuries |
WO1998007425A1 (fr) * | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Composes d'imidazole, compositions les contenant et leur utilisation |
ATE264318T1 (de) | 1996-11-19 | 2004-04-15 | Amgen Inc | Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel |
US6410729B1 (en) | 1996-12-05 | 2002-06-25 | Amgen Inc. | Substituted pyrimidine compounds and methods of use |
US6096753A (en) * | 1996-12-05 | 2000-08-01 | Amgen Inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
AP999A (en) * | 1997-01-10 | 2001-08-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
US5965583A (en) | 1997-04-24 | 1999-10-12 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory disease |
US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
US6979686B1 (en) | 2001-12-07 | 2005-12-27 | Pharmacia Corporation | Substituted pyrazoles as p38 kinase inhibitors |
US6087496A (en) * | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
AU7726898A (en) | 1997-05-22 | 1998-12-11 | G.D. Searle & Co. | Pyrazole derivatives as p38 kinase inhibitors |
EP0983260A2 (fr) * | 1997-05-22 | 2000-03-08 | G.D. Searle & Co. | PYRAZOLES 3(5)-HETEROARYL SUBSTITUEES UTILISEES COMME INHIBITEURS DE KINASE p38 |
CZ9904452A3 (cs) | 1997-06-12 | 2002-02-13 | Rhone-Poulenc Rorer Limited | Cyklické acetaly imidazolylu, způsob jejich přípravy, jejich pouľití a farmaceutický prostředek, který je obsahuje |
AU7966198A (en) | 1997-06-13 | 1998-12-30 | Smithkline Beecham Corporation | Novel pyrazole and pyrazoline substituted compounds |
US6610695B1 (en) | 1997-06-19 | 2003-08-26 | Smithkline Beecham Corporation | Aryloxy substituted pyrimidine imidazole compounds |
KR20010014288A (ko) * | 1997-06-30 | 2001-02-26 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 염증성 질환의 치료에 유용한 2-치환된 이미다졸 |
TW517055B (en) * | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
US6489325B1 (en) | 1998-07-01 | 2002-12-03 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
AR016294A1 (es) * | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
US7301021B2 (en) * | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
AU8381098A (en) * | 1997-07-02 | 1999-01-25 | Smithkline Beecham Corporation | Novel cycloalkyl substituted imidazoles |
EP1041989A4 (fr) * | 1997-10-08 | 2002-11-20 | Smithkline Beecham Corp | Nouveaux composes substitues de cycloalcenyle |
CA2316296A1 (fr) * | 1997-10-10 | 1999-04-22 | Imperial College Of Science, Technology And Medicine | Emploi de composes de csaidtm pour le traitement des contractions uterines |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
US7041694B1 (en) | 1997-12-17 | 2006-05-09 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
AR017219A1 (es) | 1997-12-19 | 2001-08-22 | Smithkline Beecham Corp | Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento |
JP2002516322A (ja) | 1998-05-22 | 2002-06-04 | スミスクライン・ビーチャム・コーポレイション | 新規2−アルキル置換イミダゾール化合物 |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO1999061440A1 (fr) * | 1998-05-26 | 1999-12-02 | Smithkline Beecham Corporation | Nouveaux composes d'imidazole substitue |
AU4395399A (en) * | 1998-07-02 | 2000-01-24 | Sankyo Company Limited | Five-membered heteroaryl compounds |
US6207687B1 (en) * | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
EP1112070B1 (fr) * | 1998-08-20 | 2004-05-12 | Smithkline Beecham Corporation | Nouveaux composes de triazole substitues |
DE69914357T2 (de) | 1998-11-04 | 2004-11-11 | Smithkline Beecham Corp. | Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
US6469018B1 (en) | 1999-01-08 | 2002-10-22 | Smithkline Beecham Corporation | Compounds |
US6930101B1 (en) | 1999-05-17 | 2005-08-16 | The Regents Of The University Of California | Thiazolopyrimidines useful as TNFα inhibitors |
AU781849C (en) * | 1999-06-17 | 2006-03-02 | Synta Pharmaceuticals Corp. | Inhibitors of IL-12 production |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
IL137365A0 (en) * | 1999-07-21 | 2001-07-24 | Sankyo Co | Heteroaryl-substituted pyrrole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
AU1782301A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p39 kinase inhibitors |
ES2241675T3 (es) | 1999-11-23 | 2005-11-01 | Smithkline Beecham Corporation | Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de cspb/p38 quinasa. |
WO2001038312A1 (fr) | 1999-11-23 | 2001-05-31 | Smithkline Beecham Corporation | COMPOSES DE 3,4-DIHYDRO-(1H)QUINAZOLINE-2-ONE UTILISES COMME INHIBITEURS DE LA KINASE CSBP/p38 |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
JP2003523954A (ja) * | 1999-12-08 | 2003-08-12 | ファルマシア コーポレイション | 治療効果が迅速に開始されるシクロオキシゲナーゼ−2阻害剤組成物 |
US20020002169A1 (en) * | 1999-12-08 | 2002-01-03 | Griffin John H. | Protein kinase inhibitors |
US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
US6525051B2 (en) | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
CA2414674A1 (fr) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Utilisation d'inhibiteurs de cox-2 pour le traitement et la prevention de troubles oculaires a mediation cox-2 |
DK1303265T3 (da) | 2000-07-20 | 2007-11-12 | Lauras As | Anvendelse af COX-2-inhibitorer, som immunostimulerende midler ved behandling af HIV eller AIDS |
EP1333833B1 (fr) | 2000-10-23 | 2011-08-24 | GlaxoSmithKline LLC | Nouveau composé 8H-pyrido[2,3-d]pyrimidin-7-one trisubstituté pour le traitement des maladies faisant intervenir les kinases CSBP/p38 |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
EP1361225B1 (fr) | 2001-01-22 | 2007-11-07 | Sankyo Company, Limited | Composes substitues avec des groupes amines bicycliques |
CN1800178A (zh) | 2001-03-26 | 2006-07-12 | 奥索-麦克尼尔药品公司 | 制备四取代咪唑衍生物及其新型晶体结构的方法 |
PE20021017A1 (es) | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
WO2002094267A1 (fr) * | 2001-05-24 | 2002-11-28 | Sankyo Company, Limited | Preparation pharmaceutique pour prevenir ou traiter l'arthrite |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
MXPA04003729A (es) * | 2001-10-22 | 2004-07-23 | Tanabe Seiyaku Co | Compuestos de 4-imidazolin-2-ona. |
AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
US6982259B2 (en) * | 2002-04-30 | 2006-01-03 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
DE60310730T2 (de) | 2002-07-09 | 2007-05-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
EP1539121A4 (fr) | 2002-08-29 | 2008-08-13 | Scios Inc | Methode pour favoriser l'osteogenese |
UA80296C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Imidazolopyridines and methods of making and using the same |
UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
EP1560488B1 (fr) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Agents antibacteriens |
AU2003288443B2 (en) * | 2002-12-16 | 2007-10-25 | Astrazeneka Uk Limited | Process for the preparation of pyrimidine compounds |
CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
CL2004000366A1 (es) * | 2003-02-26 | 2005-01-07 | Pharmacia Corp Sa Organizada B | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. |
US7244441B2 (en) | 2003-09-25 | 2007-07-17 | Scios, Inc. | Stents and intra-luminal prostheses containing map kinase inhibitors |
BRPI0417543A (pt) * | 2003-12-12 | 2007-03-27 | Wyeth Corp | quinolinas úteis no tratamento de doença cardiovascular |
AU2004305318A1 (en) * | 2003-12-18 | 2005-07-07 | Pfizer Products Inc. | Methods of treating acute inflammation in animals with p38 MAP kinase inhibitors |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
CN101010421B (zh) * | 2004-08-31 | 2011-08-03 | 三洋化成工业株式会社 | 表面活性剂 |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
EP1676574A3 (fr) | 2004-12-30 | 2006-07-26 | Johnson & Johnson Vision Care, Inc. | Procédé favorisant la survie des tissus ou cellules griffées |
CN101495475A (zh) * | 2005-03-25 | 2009-07-29 | 葛兰素集团有限公司 | 制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法 |
AR053346A1 (es) | 2005-03-25 | 2007-05-02 | Glaxo Group Ltd | Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38 |
WO2006116355A1 (fr) * | 2005-04-22 | 2006-11-02 | Kalypsys, Inc. | Inhibiteurs ortho-terphenyle de kinase p38 et procedes de traitement des troubles inflammatoires |
US20060281788A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor |
US8859602B2 (en) * | 2006-04-20 | 2014-10-14 | Janssen Pharmaceutica Nv | Inhibitors of c-fms kinase |
US8697716B2 (en) | 2006-04-20 | 2014-04-15 | Janssen Pharmaceutica Nv | Method of inhibiting C-KIT kinase |
KR101367645B1 (ko) | 2006-04-20 | 2014-02-27 | 얀센 파마슈티카 엔.브이. | C-fms 키나제의 저해제로서의 복소환식 화합물 |
EP1992344A1 (fr) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3 |
AU2008261030A1 (en) * | 2007-06-05 | 2008-12-11 | Western States Biopharmaceuticals, Inc. | T-cell cytokine-inducing surface molecules and methods of use |
JO3240B1 (ar) | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
WO2010091324A1 (fr) * | 2009-02-06 | 2010-08-12 | Western States Biopharmaceuticals, Inc. | Double inhibition de membres de la famille des immunophilines/cyclophilines et de membres de la superfamille des récepteurs d'immunoglobulines emmprin |
ES2608628T3 (es) | 2012-08-07 | 2017-04-12 | Janssen Pharmaceutica Nv | Procedimiento para la preparacion de derivados de ester heterociclicos |
JOP20180012A1 (ar) | 2012-08-07 | 2019-01-30 | Janssen Pharmaceutica Nv | عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد |
CN104903316B (zh) * | 2012-08-16 | 2017-11-28 | 詹森药业有限公司 | 作为n型钙通道阻滞剂的取代的吡唑 |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
CN104402823B (zh) * | 2014-11-05 | 2016-03-23 | 上海浩登材料科技有限公司 | 一种1,2-二甲基咪唑的制备方法 |
CN104496906B (zh) * | 2014-11-05 | 2016-03-23 | 上海浩登材料科技有限公司 | 一种咪唑的制备方法 |
EP3273955A4 (fr) | 2015-03-23 | 2019-05-01 | The University of Melbourne | Traitement de maladies respiratoires |
US20200079757A1 (en) * | 2017-05-03 | 2020-03-12 | The University Of Melbourne | Compounds for the treatment of respiratory diseases |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
WO2019071147A1 (fr) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | Inhibiteurs de la kinase p38 réduisant l'expression du gène dux4 et des gènes aval pour le traitement de la fshd |
JP2022507118A (ja) * | 2018-11-07 | 2022-01-18 | ザ ユニヴァーシティー オブ メルボルン | 呼吸器疾患の処置のための化合物及び組成物 |
FR3097222B1 (fr) * | 2019-06-11 | 2021-05-28 | Michelin & Cie | Nouveaux composes 1,3-dipolaires comprenant un heterocycle aromatique et un cycle imidazole |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2037858A5 (fr) * | 1969-03-11 | 1970-12-31 | Glaxo Lab Ltd | |
US3707475A (en) * | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
US3940486A (en) * | 1971-05-10 | 1976-02-24 | Ciba-Geigy Corporation | Imidazole derivatives in the treatment of pain |
US3929807A (en) * | 1971-05-10 | 1975-12-30 | Ciba Geigy Corp | 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles |
US4058614A (en) * | 1973-12-04 | 1977-11-15 | Merck & Co., Inc. | Substituted imidazole compounds and therapeutic compositions therewith |
US4199592A (en) * | 1978-08-29 | 1980-04-22 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-2-nitroimidazoles |
DD201677A5 (de) * | 1980-07-25 | 1983-08-03 | Ciba Geigy | Verfahren zur herstellung von trisubstituierten imidazolderivaten |
US4503065A (en) * | 1982-08-03 | 1985-03-05 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl 1-2-halo imidazoles |
US4565875A (en) * | 1984-06-27 | 1986-01-21 | Fmc Corporation | Imidazole plant growth regulators |
US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
IE59893B1 (en) * | 1986-04-16 | 1994-04-20 | Roussel Uclaf | Process for the manufacture of n-(sulfonylmethyl) formamides |
IL83467A0 (en) * | 1986-08-15 | 1988-01-31 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same |
ZA919797B (en) * | 1990-12-13 | 1992-10-28 | Smithkline Beecham Corp | Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones |
CA2098177A1 (fr) * | 1990-12-13 | 1992-06-13 | Jerry L. Adams | Csaids |
DE69322254T2 (de) * | 1992-01-13 | 1999-04-29 | Smithkline Beecham Corp., Philadelphia, Pa. 19101 | Pyridyl-substituierte imidazole |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
ZA945363B (en) * | 1993-07-21 | 1995-03-14 | Smithkline Beecham Corp | Novel compounds |
KR19980701374A (ko) * | 1995-01-12 | 1998-05-15 | 스티븐 베네티아너 | 신규 화합물(Novel Compounds) |
-
1995
- 1995-06-07 US US08/472,366 patent/US5593992A/en not_active Expired - Lifetime
- 1995-12-19 IL IL13432395A patent/IL134323A/en not_active IP Right Cessation
- 1995-12-19 IL IL13432295A patent/IL134322A/en not_active IP Right Cessation
- 1995-12-19 IL IL13432495A patent/IL134324A/xx unknown
- 1995-12-19 IL IL11645595A patent/IL116455A/en not_active IP Right Cessation
-
1996
- 1996-01-03 IN IN11DE1996 patent/IN184957B/en unknown
- 1996-01-05 MA MA24125A patent/MA23770A1/fr unknown
- 1996-01-05 AR ARP960100903A patent/AR002267A1/es unknown
- 1996-01-06 DZ DZ960002A patent/DZ1961A1/fr active
- 1996-01-09 ID IDP990848D patent/ID23599A/id unknown
- 1996-01-09 ID IDP990850D patent/ID23273A/id unknown
- 1996-01-09 ID IDP990849D patent/ID23597A/id unknown
- 1996-01-11 WO PCT/US1996/000546 patent/WO1996021452A1/fr not_active Application Discontinuation
- 1996-01-11 DK DK96902151T patent/DK0809499T3/da active
- 1996-01-11 HU HU9702409A patent/HUP9702409A3/hu unknown
- 1996-01-11 BR BR9606904A patent/BR9606904A/pt active Search and Examination
- 1996-01-11 CN CNB961922982A patent/CN1138546C/zh not_active Expired - Fee Related
- 1996-01-11 EP EP96902151A patent/EP0809499B1/fr not_active Expired - Lifetime
- 1996-01-11 PT PT96902151T patent/PT809499E/pt unknown
- 1996-01-11 SK SK902-97A patent/SK90297A3/sk unknown
- 1996-01-11 MX MX9705142A patent/MX9705142A/es unknown
- 1996-01-11 AT AT96902151T patent/ATE254613T1/de not_active IP Right Cessation
- 1996-01-11 SI SI9630660T patent/SI0809499T1/xx unknown
- 1996-01-11 AP APAP/P/1997/001021A patent/AP1270A/en active
- 1996-01-11 JP JP52186296A patent/JP3330952B2/ja not_active Expired - Fee Related
- 1996-01-11 PL PL96322249A patent/PL322249A1/xx unknown
- 1996-01-11 CZ CZ972158A patent/CZ215897A3/cs unknown
- 1996-01-11 DE DE69630777T patent/DE69630777T2/de not_active Expired - Fee Related
- 1996-01-11 ES ES96902151T patent/ES2210348T3/es not_active Expired - Lifetime
- 1996-01-11 AU AU46572/96A patent/AU705207C/en not_active Ceased
- 1996-01-11 EP EP02078189A patent/EP1264827A1/fr not_active Withdrawn
- 1996-01-11 NZ NZ301204A patent/NZ301204A/xx unknown
- 1996-01-11 CA CA002209938A patent/CA2209938A1/fr not_active Abandoned
- 1996-01-11 RU RU97113753/04A patent/RU2196139C2/ru not_active IP Right Cessation
- 1996-03-18 TW TW085103208A patent/TW523511B/zh not_active IP Right Cessation
- 1996-08-21 US US08/702,250 patent/US5663334A/en not_active Expired - Lifetime
-
1997
- 1997-03-17 US US08/819,619 patent/US6103936A/en not_active Expired - Fee Related
- 1997-07-02 BG BG101727A patent/BG63769B1/bg unknown
- 1997-07-08 FI FI972901A patent/FI972901A/fi not_active IP Right Cessation
- 1997-07-08 NO NO973167A patent/NO973167L/no unknown
- 1997-07-09 OA OA70045A patent/OA10738A/en unknown
-
1998
- 1998-04-09 HK HK98103016A patent/HK1003623A1/xx not_active IP Right Cessation
-
2000
- 2000-01-27 IN IN60DE2000 patent/IN188338B/en unknown
- 2000-01-27 IN IN61DE2000 patent/IN188339B/en unknown
- 2000-02-01 IL IL13432400A patent/IL134324A0/xx unknown
- 2000-02-01 IL IL13432200A patent/IL134322A0/xx unknown
- 2000-02-01 IL IL13432300A patent/IL134323A0/xx unknown
- 2000-02-11 US US09/502,763 patent/US6222036B1/en not_active Expired - Fee Related
-
2001
- 2001-02-27 US US09/795,009 patent/US20020188122A1/en not_active Abandoned
- 2001-07-16 JP JP2001215404A patent/JP2002105047A/ja active Pending
- 2001-12-19 NO NO20016225A patent/NO20016225D0/no not_active Application Discontinuation
- 2001-12-19 NO NO20016226A patent/NO20016226D0/no not_active Application Discontinuation
-
2002
- 2002-08-15 RU RU2002122174/14A patent/RU2002122174A/ru not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ1961A1 (fr) | Nouveaux composés. | |
DZ1989A1 (fr) | Nouveaux composés. | |
DZ1798A1 (fr) | Nouveaux composés. | |
TR199501724A2 (tr) | Sizdirmazlik saglayici düzen. | |
DE69636353D1 (de) | Datenübetragungsvorrichtung. | |
NL1004863A1 (nl) | 5-Amino-4-ethylsulfinyl-1-arylpyrazolen. | |
FI950715A0 (fi) | Ytmikromekanisk, symmetrisk tryckskillnadsgivare | |
NL1000095C2 (nl) | Rolhor. | |
DK0874814T3 (da) | 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler | |
DZ2446A1 (fr) | Nouveaux composés | |
FR2720395B1 (fr) | Nouveaux composés de la famille des benzohétérocycles. | |
ES1032571Y (es) | Gafa, | |
DZ2241A1 (fr) | Composés nouveaux. | |
TR199600665A2 (tr) | Asimetrik trifenilendioksazin bilesikleri. | |
FI952782A0 (fi) | Braennare, i synnerhet foer foerbraenning av flytande braensle och en braensle-vattenblandning | |
FI954044A0 (fi) | Foerfarande, anordning och bruk saerskilt foer avlaegnande av arsin ifraon vatten | |
FI954754A0 (fi) | Anordning foer kvistning, kupning och klyvning av traed | |
FI950956A0 (fi) | Luftkabel, saosom haengspiralkabel | |
FI952416A0 (fi) | Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor | |
FIU950492U0 (fi) | Stadigt, laetthanterligt och flyttbart klaedstaell | |
FI955780A0 (fi) | Foerfarande, borrningsanordning och bruk foer borrning | |
FI950577A0 (fi) | Installationsgolv, installationsfoerfarande och anvaendning | |
ES1032458Y (es) | Estrctura porta-bidones. | |
ES1030027Y (es) | Cama-somier supletoria. | |
FI950199A0 (fi) | Foergjuten, eldfast fodring foer ett tryckkaerls roer- och kammarvaeggar |